Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

Kelly E. Dooley, Radojkam Savic, Akshay Gupte, Mark A. Marzinke, Nan Zhang, Vinodh A. Edward, Lisa Wolf, Modulakgotla Sebe, Morongwe Likoti, Mark J. Fyvie, Innocent Shibambo, Trevor Beattie, Richard E. Chaisson, Gavin J. Churchyard

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences